U.S. Stock News

Inspire Medical Systems (INSP) reported net profit margins of 5%, up from 4.4% the previous year, signaling improved profitability. The company has transitioned to steady profits over the past five years, averaging 56.3% annual earnings growth. However, the most recent year saw earnings rise by 34.8%. Forecasts call for 25.6% annual EPS growth and revenue expansion of 10.7% per year, both outpacing the US market. Investors are likely weighing robust future prospects against a premium...

If you have ever wondered whether Vertex stock is trading at a bargain or an inflated price, you are in the right place for some answers. After a rough few months, Vertex shares have dropped by 20.7% over the last week and are down 54.4% over the past year, suggesting a dramatic shift in market sentiment around the company. Much of this decline has been set against a backdrop of challenging headlines, including industry-wide volatility in the software sector, as well as broader market...

CVR Partners (NYSE:UAN) just released third quarter results that showed a sharp rise in both earnings and cash distribution compared to last year, giving investors plenty to talk about this week. See our latest analysis for CVR Partners. After such a jump in earnings and another bump to its distribution, it’s no surprise investors have taken notice. CVR Partners’ share price is up 27.3% year-to-date, while the one-year total shareholder return stands at an impressive 63.3%. Momentum has built...

Wondering if Fastly could be a hidden gem or just another risky play? Let’s break down what’s driving interest in the stock right now and whether its current price tells the full story. Fastly’s share price has been bouncing around recently, with a -4.0% move in the last week and down nearly 10% over the past month. However, it is still sitting about 3.8% higher than a year ago. Recent headlines highlight Fastly’s rollout of new edge cloud technologies and ongoing partnerships with major...

Ever wondered if Insulet is actually worth its current share price? You are not alone in wanting to know whether this fast-growing company could offer real value, or if the opportunity has already passed by. Insulet's stock has climbed 24.7% year-to-date and an impressive 32.7% over the last year, but it has pulled back a modest 1.3% in the past week, hinting at some recent volatility. News around advancements in Insulet’s Omnipod technology and expanding market access has continued to...

In October 2025, Visteon Corporation reported third-quarter earnings, with net income increasing to US$57 million despite lower sales, and announced its first quarterly dividend alongside plans for technology-focused acquisitions supported by a net cash position of US$459 million. This combination of higher earnings, a new dividend, and acquisition ambitions underscores Visteon's focus on balanced capital allocation and future technological growth. We'll explore how Visteon's initiation of a...

Corebridge Financial (CRBG) has turned the corner to profitability over the last year, with forecasts now calling for earnings growth of 51.05% per year. That is more than triple the broader US market average of 16%. Revenue is set to grow at a slower pace of 7.6% per year, which trails the US market’s 10.5% growth. Margins have also rebounded as the company moved from losses into positive territory, drawing attention as a potential turnaround story this earnings season. See our full analysis...

Premier (PINC) reported a net profit margin of just 0.7% this quarter, a sharp drop from last year’s 11.2%, with earnings having declined at an average annual rate of -25.5% over the past five years. Despite recent pressures, the company is now profitable and is forecasting a robust 32.6% annual earnings growth over the next three years, which is double the 16% expected for the US market overall. These mixed results, combined with a one-off $162.9 million loss, have pushed Premier’s shares to...

PJT Partners (PJT) posted a net profit margin of 10.7%, up from 8% last year, signaling improved profitability. Earnings are on a tear, with annual growth hitting 64.9%, far exceeding the firm’s 5-year average of 6.4% per year and pointing to a period of rapid acceleration. Despite this robust earnings momentum, analysts expect future earnings to contract by 2.8% per year while revenue growth is forecast at 8.6%, trailing the broader US market’s 10.5% pace. This may lead investors to...

Kura Oncology (KURA) remains unprofitable and is projected to stay in the red for at least the next three years, with losses having widened at a pace of 15.3% per year over the last five. Despite negative profit margins and no signs of bottom-line improvement, the company is forecast to deliver revenue growth of 42.7% annually, significantly outpacing the broader US market’s 10.5% revenue growth expectation. Investors now face a trade-off between robust top-line growth potential and the...

ONE Gas (OGS) reported net profit margins of 10.8%, slightly ahead of last year’s 10.5%, as annual earnings growth reached 17.7%, substantially outpacing the company’s five-year average of 4.5%. Earnings are forecast to grow at 8.94% per year, but both profit and revenue trends remain below broader US market averages. Investors will note that despite stronger bottom-line results, valuation appears mixed given that the stock’s Price-to-Earnings ratio sits between its US and global gas utility...

Wondering if ONEOK might be a hidden value in the energy sector? Let’s dig into whether the numbers back up that gut feeling, especially if you are looking for opportunities others might have missed. The stock has had a rough patch recently, sliding 6.9% over the past week and 11.8% over the last month, with a year-to-date drop of 36.8% and a one-year loss of 31.4%. Looking at a longer timeline, over five years shares are still up an impressive 164.5%. Some of the recent price movement...

Harmony Biosciences Holdings (HRMY) delivered a net profit margin of 22.5% this period, well above last year's 18%. Earnings grew by 51.4% over the past year, outpacing both its own five-year average growth rate of 40.8% and broader US market expectations. Looking ahead, analysts forecast earnings to grow 20.5% per year, surpassing the US market's 16%, while revenue is expected to rise at 12.7% annually compared to the market's 10.5% pace. This combination of sustained profitability and...

On November 3, 2025, Prelude Therapeutics announced a private placement, raising US$25,000,000 by issuing 6,250,000 shares at US$4 each, with participation from Incyte Corporation. Institutional interest from a company like Incyte can be viewed as an endorsement of Prelude’s research direction and funding outlook. We’ll explore how Incyte’s involvement in the private placement shapes Prelude’s investment narrative and financial flexibility. The best AI stocks today may lie beyond giants like...

Expeditors International of Washington (EXPD) reported a net profit margin of 7.6%, up from 7.4% a year ago, signaling a modest expansion in profitability. Earnings grew 15.4% over the past year. However, the longer-term five-year trend shows a decline of 6% per year. Looking ahead, analysts expect earnings to decline by 1.1% annually over the next three years, along with minimal revenue growth of 0.2% per year. This trails well behind the broader US market's projected 10.5% annual rate. The...

Wondering if StepStone Group is a hidden gem or getting pricey? You are not alone, and we're here to break down the numbers in plain English. The stock has seen returns of 5.4% year-to-date and 5.9% over the last year, despite minor pullbacks in the last week and month. StepStone's share price has been influenced by recent headlines detailing its continued expansion in private markets and new fund launches, which have caught the eye of both industry watchers and investors. This activity has...

Better Home & Finance (BETR) is in the spotlight after activist investor Eric Jackson endorsed the company for its ability to transform the mortgage sector using AI and digital technologies. Jackson drew comparisons to top e-commerce innovators. See our latest analysis for Better Home & Finance Holding. Shares of Better Home & Finance have been on a tear, climbing a remarkable 609.96% year-to-date in terms of share price return, with explosive momentum particularly in the last quarter. While...

Capital Southwest (CSWC) posted net profit margins of 39.5%, up from last year’s 37.8%. The company remained profitable despite a substantial one-off loss of $35.6 million in its latest results. Over the past 5 years, earnings grew at an annual rate of 24.8%, while this year’s earnings growth slowed to 16.4%. With shares currently trading at a price-to-earnings ratio of 13x, CSWC is drawing attention from valuation-focused investors. However, the slower revenue growth and significant...

First Watch Restaurant Group (FWRG) reported a net profit margin of 0.4% this quarter, slipping from 2.1% last year as margins tightened. While a $2.5 million one-off loss weighed on trailing results and short-term earnings growth was negative, the company has turned profitable over the last five years with robust compound growth. Despite mixed financial signals, investors are taking note of optimistic forecasts, with earnings expected to climb 39.3% annually over the next three years, well...

CDW (CDW) posted average annual earnings growth of 5.3% over the past five years, with earnings now forecast to accelerate to 9.4% per year ahead. Revenue is expected to rise by 3.7% annually, which trails the broader US market's 10.5% pace. Net profit margin narrowed to 4.8% from 5.3% last year, signaling some pressure on profitability. However, investor attention is also drawn to attractive dividends, ongoing growth, and CDW's favorable valuation versus industry benchmarks. See our full...

Spotify Technology (SPOT) delivered standout results this earnings season, with net profit margins reaching 8.3%, up sharply from 4.6% previously, and EPS growth an impressive 100.4% year-over-year compared to its 5-year average of 56% per year. The company’s forward guidance calls for continued momentum, forecasting annual EPS growth of 26.8% and revenue growth of 12%, both outpacing the broader US market. With current profitability trends and no major risks identified in the latest filings,...

SunCoke Energy (SXC) faces a tough road ahead, with earnings projected to decline by 2.3% per year and revenue expected to contract at an even sharper rate of 8.5% annually over the next three years. The company’s net profit margin has slipped to 3.5%, down from 4.4% the year before, reflecting a negative turn in recent profitability after five years of strong average annual profit growth. As a result, investors are likely viewing SunCoke’s earnings update as a move from years of expansion...

MPLX (MPLX) posted net profit margins of 40% for the latest period, up from 38.9% a year ago, signaling stronger profitability. While the company achieved an impressive 24% annual earnings growth rate over the past five years, its most recent annual growth of 11.9% points to a slower pace. Future forecasts now call for earnings and revenue to grow at 4.71% and 5.1% per year, respectively, which trails broader US market averages. Despite the slowdown, attractive valuation metrics and the...

Gladstone Commercial (GOOD) is forecasting earnings growth of 20.6% per year, outpacing the US market’s expected 16% annual growth rate. Over the last five years, the company’s earnings have grown at an impressive average rate of 41.7% each year, and earnings quality remains high. Revenue growth is projected at 5.5% per year, trailing the broader US market average of 10.5%. Net profit margin stands at 5.4%, just below last year’s 5.7%. With shares currently trading at $10.7, below both...